Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune Diseases

References

• Polliack, A. and Lugassy, G. (1992) "Autoimmunity and autoimmune syndromes associated with and preceding the development of lymphoproliferative disorders". Leukemia 6\(Suppl. 4), 152.
   PubMed Web of Science ®Google Scholar
• Foon, K.A., Rai, K.R. and Gale, R.P. (1990) "Chronic lymphocytic leukemia: new insight into biology and therapy", Ann. Intern. Med. 113, 525.
   PubMed Web of Science ®Google Scholar
• Hamblin, T.J., Oscier, D.G. and Young, B.J. (1986) "Autoimmunity in chronic lymphocytic leukaemia", J. Clin. Pat/to!. 39, 713–716.
   PubMed Web of Science ®Google Scholar
• Diehl, L.F. and Ketchum, L.H. (1988) "Autoimmune disease and chronic lymphocytic leukemia, pure red cell aplasia and autoimmune thrombocytopenia", Semin. Oncol. 25, 80–97.
   Google Scholar
• Mauro, F., Fao, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F. and Girelli, G. (2000) "Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic and prognostic features", Blood 95, 2786–2792.
   PubMed Web of Science ®Google Scholar
• Mitsui, Y., Kusunoki, S., Hiruma, S., Akamatsu, M., Kihara, M., Hashimoto, S. and Takahashi, M. (1999) "Sensorimotor polyneuro-pathy associated with chronic lymphocytic leukemia. IgM antigangliosides antibody and human T cell leukemia virus I infection", Muscle Nerve 22, 1461–1465.
   PubMed Web of Science ®Google Scholar
• Maloney, D.G., Grillo-Lopez, A.J., White, C.A., Bodkin, D., Schilder, R.J., Neidhart, J.A., Janakiraman, N., Foon, K.A., Liles, T.M., Dallaire, B.K., Wey, K., Royston, I., Davis, T. and Levy, R. (1997) "IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma", Blood 90, 2188–2195.
   PubMed Web of Science ®Google Scholar
• McLaughlin, P., Grillo-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruclder, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. and Dallaire, B.K. (1998) "Rituximab chimeric anti CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program", 1 Clin. Oncol. 16, 2825–2833.
   Google Scholar
• Huhn, D., von Shilling, A., Wilhelm, M., Ho, A., Hallek, M., Knauf, W., Riedel, U., Srock, S., Serke, S. and Emmerich, B. (2000) "Rituximab therapy of patient with B-cell chronic lymphocytic leukemia", Blood 98, 1321–1326.
   Google Scholar
• Stasi, R., Pagano, A., Stipa, E. and Amadori, S. (2001) "Rituximab chimeric anti CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenia purpura", Blood 98, 952–957.
   PubMed Web of Science ®Google Scholar
• Ahrens, N., Kingreen, D., Seltsman, A. and Salama, A. (2001) "Treatment of refractory autoimmune hemolytic anemia with anti-CD20 (rituximab)", Br J. Haematol. 114, 244–245.
   PubMed Web of Science ®Google Scholar
• Zaja, F., lacona, I., Masolini, P., Russo, D., Sperotto, A., Prosdocimo, S., Patriarca, F., De Vita, S., Ragazzi, M., Baccarani, M. and Fanin, R. (2002) "B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombo-cytopenia", Haematologica 87, 189–195.
   PubMed Web of Science ®Google Scholar
• Berentsen, S., Tjonnfjord, G.E., Brudevold, R., Gjertsen, B.T., Langholm, R., Lokkevik, E., Sorbo, J.H. and Ulvestad, E. (2001) "Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary cold agglutinin disease", Br J. Haematol. 115, 79–83.
   PubMed Web of Science ®Google Scholar
• Zaja, F., De Vita, S., Russo, D., Michelutti, A., Fanin, R., Ferraccioli, G. and Baccarani, M. (2002) "Rituximab for the treatment of type II mixed Cryoglobulinemia", Arthritis Rheum. 46, 2252–2254.
   PubMed Web of Science ®Google Scholar
• Zecca, M., De Stefano, P., Nobili, B. and Locatelli, F. (2001) "Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia", Blood 97, 3995 —3997.
   PubMed Web of Science ®Google Scholar
• flegde, U.P., Wilson, W.H., White, T. and Cheson, B.D. (2002) "Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia", Blood 100, 2260–2262.
   PubMed Web of Science ®Google Scholar
• Seipelt, G., Bohme, A., Koschmieder, S. and Hoelzer, D. (2001) "Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome", Ann. Hematol. 80, 170–173.
   PubMed Web of Science ®Google Scholar
• Iannito, E., Ammatuna, E., Marino, C., Cirrincione, S., Greco, G. and Mariani, G. (2002) "Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody", Blood 99, 1096— 1097.
   PubMed Web of Science ®Google Scholar
• Gupta, N., Kavuru, S., Patel, D., Janson, D., Driscoll, N., Ahmed, S. and Rai, K.R. (2002) "Rituximab-based chemotherapy for steroid-refractory autoimmune haemolytic anemia of chronic lymphocytic leukaemia", Leukemia 116, 2092–2095.
   Web of Science ®Google Scholar
• Ghazal, H. (2002) "Succesful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukaemia", Blood 99, 1092–1094.
   PubMed Web of Science ®Google Scholar